The Power List is our chance to put the pharmaceutical and drug development industry’s inspirational thought leaders, opinion shapers and unsung heroes in the spotlight. We’re relying on you to ensure that the breadth of perspectives is as wide as possible!
personalized, responsive service and to improve the site, we remember and store information about how you use
The Medicine Maker
“Industry 4.0 – what does it mean and why should biopharma care? In this month’s cover feature we ask biopharma industry experts for their view. Meanwhile, Upfront looks at a new not-for-profit company headed up by Power List alumni Martin Van Trieste, and a paper-based assay for spotting fake antibiotics. But in In My View, Maarten Van Baelen considers the unintended consequences of fighting counterfeit medicine… Also in this issue we find out what pharma can learn from Toyota in lean manufacturing, and how sharks can influence a new generation of biotherapeutics. Finally, we Sit Down With Danny Bar-Zohar, Global Head of Neuroscience Development at Novartis, Switzerland.”